Connect with us

Health

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.ABSTRACTPURPOSE: The immunogenicity and…

Published

4 years ago

on

November 9, 2021

By

Noosa Online News Publisher

Article feature image

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.
ABSTRACT
PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood.
METHODS: We performed a prospective cohort…

Click here to view the original article.

Related Topics:Australia Docwirenews.com Featured

Australia discovers new solution to fight chronic middle ear infections – BSA bureau

Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections – News-Medical.Net

Continue Reading

Advertisement

General13 hours ago

Australian celebrity chef Peter Russell-Clarke dies aged 89

Noosa News23 hours ago

Rainbow Beach surfer’s untold 7/7 story

Noosa News15 hours ago

Woman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland

Noosa News13 hours ago

Woman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba

About Us	Contact Us

© 2025 Noosa Online News
Privacy Policy